Intrahepatic Cholangiocarcinoma
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) FDA (1) | FGFR2::v | Intrahepatic Cholangiocarcinoma | Futibatinib | |
| EMA (1) | FGFR2 rearrangements | Intrahepatic Cholangiocarcinoma | Futibatinib | |
| EMA (1) HSE (1) | FGFR2::v | Intrahepatic Cholangiocarcinoma | Elacestrant | |
| EMA (1) HSE (1) | FGFR2 rearrangements | Intrahepatic Cholangiocarcinoma | Elacestrant |